FDA — authorised 30 December 1993
- Marketing authorisation holder: GENENTECH
- Status: approved
🇺🇸 Pulmozyme in United States
FDA authorised Pulmozyme on 30 December 1993
Marketing authorisation
Pulmozyme in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Pulmozyme approved in United States?
Yes. FDA authorised it on 30 December 1993.
Who is the marketing authorisation holder for Pulmozyme in United States?
GENENTECH holds the US marketing authorisation.